SCHEMBL4768653

SCHEMBL4768653

CCN1CCN(c2nc(-c3ccccc3OC)cc3ccccc23)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 2/20 0.48
TSHR P16473 1/20 0.48
MAPT P10636 4/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
KDM4E B2RXH2 1/20 0.48
GLA P06280 1/20 0.48
GAA P10253 1/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
CYP2C19 P33261 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
USP2 O75604 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPK1 P28482 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
RAD52 P43351 1/20 0.44
NTSR1 P30989 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6292095 0.99 KMT2A (0.48) CYP1A2CYP3A4TSHRMAPTALDH1A1
SCHEMBL6292035 0.91 MAPT (0.45) CYP1A2CYP3A4TSHRMAPTALDH1A1
Hydrochloric Acid SCHEMBL4772865 0.90 KMT2A (0.45) CYP1A2CYP3A4TSHRMAPTALDH1A1
SCHEMBL4773632 0.90 KMT2A (0.46) CYP1A2MAPTALDH1A1HPGDKMT2A
SCHEMBL4774677 0.89 LMNA (0.47) CYP1A2MAPTALDH1A1HPGDKDM4E
SCHEMBL4773255 0.89 MAPT (0.45) CYP1A2CYP3A4TSHRMAPTALDH1A1
SCHEMBL4769162 0.89 KDM4E (0.48) CYP1A2CYP3A4TSHRMAPTALDH1A1
Hydrochloric Acid SCHEMBL4767279 0.89 KMT2A (0.46) CYP1A2TSHRMAPTALDH1A1HPGD
Hydrochloric Acid SCHEMBL4772567 0.88 LMNA (0.47) CYP1A2MAPTALDH1A1HPGDKDM4E
Hydrochloric Acid SCHEMBL4767408 0.88 MAPT (0.44) CYP1A2CYP3A4TSHRMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US claimed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP claimed
EP-1020445-B1 FUSED PYRIDINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2008-08-13 EP disclosed
EP-1020445-B1 FUSED PYRIDINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2008-08-13 EP disclosed
US-6875761-B2 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. (JP) 2005-04-05 US disclosed
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. 2004-10-14 US disclosed
US-6790844-B2 MUSCLE RELAXANTS; ANTISEROTONINE AGENT EISAI CO., LTD (JP) 2004-09-14 US disclosed
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US disclosed
US-6340759-B1 ANTISPASMODIC AGENTS EISAI CO., LTD. (JP) 2002-01-22 US disclosed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013460-A1 Condensed pyridine compound MUSK, HTR1A, PAX3 CYP1A2 2126/4885CYP3A4 1309/4885TSHR 1481/4885
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives MUSK, HTR1A, RYR1 CYP1A2 1489/4885CYP3A4 1325/4885TSHR 962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.